The US move and the Takeda agreement were contained in a larger update on the Silence’s progress, one in which chairman Iain Ross said the company...
Pharma & Biotech
Reaction
Reaction
Income in the time of corona: hunting for dividends among the wreckage
Only around 40 companies committed to paying returns to shareholders this year, analysts at...
Here we take a closer look at Integumen PLC, which has developed and digitised an artificial skin
We take a closer look at ImmuPharma, the developer of a breakthrough drug for lupus
The company’s investment objective is to generate capital growth by investing in a global...
Companies involved in diagnostics, drug development and medical equipment provision have all...
Headlines from the Proactive UK newsroom. London’s leading shares are set to open on the back foot this morning ahead of the release later of US jobs figures for March.. But economists say the full scale of the rising jobless in the US economy will be revealed in next month’s...
Pharma & Biotech
Faron Pharmaceuticals CEO details new global pneumonia trial for...
Market Report
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
